Why the study?
It is unclear when and how peripheral centers should interact with referral centers with specific expertise and access to second-line diagnostic tools and therapies for nonischemic-dilated cardiomyopathy patients.
Answers are grounded in this paper and cite their sources.
This position paper provides a framework for the management of nonischemic-dilated cardiomyopathy, emphasizing the necessary interactions between peripheral and referral centers.
: Nonischemic-dilated cardiomyopathy (NIDCM) is an entity that gathers extremely heterogeneous diseases. This awareness, although leading to continuous improvement in survival, has increased the complexity of NIDCM patients' management. Even though the endorsed 'red-flags' approach helps clinicians in pursuing an accurate etiological definition in clinical practice, it is not clear when and how peripheral centers should interact with referral centers with specific expertise in challenging scenarios (e.g. postmyocarditis and genetically determined dilated cardiomyopathy) and with easier access to second-line diagnostic tools and therapies. This position paper will summarize each step in NIDCM management, highlighting the multiple interactions between peripheral and referral centers, from first-line diagnostic workup and therapy to advanced heart failure management and long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Merlo et al. (2020) conducted a review in Nonischemic-dilated cardiomyopathy (NIDCM). Management of NIDCM was evaluated. This position paper summarizes each step in nonischemic-dilated cardiomyopathy management, highlighting interactions between peripheral and referral centers from diagnosis to long-term follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: